Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. - Wikidata - wikimedia - TriplyDB

Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

http://www.wikidata.org/entity/Q36936090

about

Cutting the brakes on hematopoietic regeneration by blocking TGFβ to limit chemotherapy-induced myelosuppression Cord Blood Banking Standards: Autologous Versus Altruistic Wharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes.Umbilical Cord Blood Transplantation: Challenges and Future Directions.Improving cord blood unit quantity and quality at King Abdullah International Medical Research Center Cord Blood Bank.Cord blood collection and banking from a population with highly diverse geographic origins increase HLA diversity in the registry and do not lower the proportion of validated cord blood units: experience of the Marseille Cord Blood Bank.High quality cord blood banking is feasible with delayed clamping practices. The eight-year experience and current status of the national Swedish Cord Blood Bank.Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.Umbilical cord blood transplantation: the first 25 years and beyond.Concise review: umbilical cord blood transplantation: past, present, and future One-unit versus two-unit cord-blood transplantation for hematologic cancers.How I treat: the selection and acquisition of unrelated cord blood grafts.High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes.Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies The use of back-up units to enhance the safety of unrelated donor cord blood transplantation Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood Banks.US public cord blood banking practices: recruitment, donation, and the timing of consent Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.Modelling improvements in cell yield of banked umbilical cord blood and the impact on availability of donor units for transplantation into adults.Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions.Immune recovery after allogeneic hematopoietic stem cell transplantation: is it time to revisit how patients are monitored?Racial disparities in hematopoietic cell transplantation in the United States.Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes.The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.Ex vivo expansion of umbilical cord blood: where are we?Blood stem cell products: toward sustainable benchmarks for clinical translation.Cord Blood Transplantation: Can We Make it Better?Are hybrid umbilical cord blood banks really the best of both worlds?Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia Update on umbilical cord blood transplantation Assessing the HLA diversity of cord blood units collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan area.

P2860

Q26745695-EBF51A03-27E7-4B44-8B0E-F3BE2B3EE87D Q26771336-4301E084-7CE6-4F2A-86F6-6E4816A5D8A0 Q28083027-7FE2D80B-DBA1-4920-8FBA-D451115C3735 Q30252975-023CDB98-8F89-4A7C-BD21-E772717AE7F5 Q30352323-077939D7-50EF-45BB-BDEE-97EB207620C2 Q33456618-7C8BC219-266C-44E2-A0C6-658B8F9D9AC4 Q33457123-ED591723-F40A-4693-88FD-606ECCE5039D Q33458350-9F059EE4-2B01-4BF2-9470-2B6DAA42B377 Q34325220-3750B51B-38FB-4B86-886D-637079DCE5C3 Q34344669-3166C5E0-7A00-4094-8824-9454ED814C2A Q34601968-5E6DC8E5-712C-44AA-970E-D15F41670EC5 Q34637605-15F45D20-569C-48E6-93D5-38FE0E5666E6 Q34707580-89C8D63E-B97A-407A-B56E-23B6099AAF6C Q34802425-65B2C1B9-E006-41AF-BBDF-D8919957BC80 Q35167190-AEEC970A-16BB-49A7-B43C-90DAC28170A7 Q35177492-1A58E2EA-A29F-4C0A-866D-E3B39BD822D7 Q35230664-7F716469-EC43-406A-B28D-2D0B95C6D981 Q35703480-481F5A3F-AD12-4155-98B0-488D3E6E2723 Q35830784-EBAD31CA-4C04-4FC8-A2D9-1D7A60F8DB1D Q35845470-9AB97C52-0524-4F2A-8A3C-0489D78BD85B Q35856939-98E00369-0563-46D7-AD71-89F38940F591 Q36335783-067D7504-7ACF-4895-A050-1E2792F47E6B Q36337955-DB36BF3E-C6F9-4FDA-B7D3-E1EC92EA905E Q36622322-73B6FD9D-3CB9-410F-A39A-7B0CF3144C0A Q36663513-53D9D00E-5787-4938-9FE6-349F6F871CA0 Q36905580-BCF43F4A-C22A-410A-B804-5B51DBB17205 Q36951734-F834112C-5FBC-4483-AF14-E73707358CCF Q37154176-3639321A-78AB-4018-A49B-B85E35529C21 Q37211141-772C05D4-BA4F-4E5C-A266-2BF5EE3589E0 Q37358914-637B37FC-2BCF-483E-A72A-BD8B714240A1 Q37417524-4382DBB2-5F56-45D8-BA97-0C333FDEBAB3 Q37555836-3B0FB8C1-B34E-431D-B0ED-A472C8B76802 Q37995979-92219789-201D-466E-B7BD-42C7C713EB8E Q38072649-53B9EAEF-11D3-45FB-8A5A-43BB80768E68 Q38142167-04A93C41-2B7A-41C9-AEB9-E5F42178DE8A Q38211592-8FE97588-8239-4C91-9BA6-61A56CE9E610 Q38747929-9328EF7B-42C3-4E37-B384-247037A02F32 Q41411372-7BF7FE08-447F-4D5D-BEAA-1FA44E39B685 Q41589103-A2A13B63-67CD-45F6-A96D-7058315B7187 Q46191094-A868847E-3E24-494F-9FDD-80819E34F8FA

P2860

Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

http://www.wikidata.org/entity/Q36936090

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Availability of cord blood ext ...... racial and ethnic minorities.

@en

type

label

Availability of cord blood ext ...... racial and ethnic minorities.

@en

prefLabel

Availability of cord blood ext ...... racial and ethnic minorities.

@en

P1433

Q36936090-E846D2B6-3651-489A-BBB8-D50A9EF91447

P1476

Q36936090-82D65454-8BD7-439C-95B0-8A4F4AACF71B

P2093

Q36936090-20377192-D58F-4EEB-B205-63E0EB83C917

Q36936090-41EFA56B-F4D2-4582-BB9F-AF5025AB4E74

Q36936090-6B820128-3BCB-474A-B975-3C072D12BBEA

Q36936090-89DC4AC1-55FE-467D-BEDB-835189C7ED94

Q36936090-91FA6783-E376-4327-A166-8189C4223746

Q36936090-92F0D742-830C-4D5E-9A87-A0BC1933DB5C

Q36936090-9524569A-BEDF-4F0E-A3B8-925642E920F3

Q36936090-9627FA1C-2A0E-4ECF-A93E-D0BD4D4C3A4E

Q36936090-B9096892-8611-4460-8065-22C3F8B09661

Q36936090-DCD78E80-BE21-4919-8D79-616610A24263

P2860

Q36936090-092EE306-79F5-4D33-8439-8DA3F46D02DD

Q36936090-1CE1A95A-698B-4C59-8FAF-172845D8E1FA

Q36936090-22D77D50-5224-4E9B-B6AB-869A0FB92774

Q36936090-26644B9F-ECEA-4978-B5AE-1CF71E590FCE

Q36936090-4190EF99-074B-4ED2-9F26-E49A944CC7BA

Q36936090-66400C50-FE26-49CB-9076-920D4B7D8321

Q36936090-694C1F31-EA5F-46CF-BD2C-147CCD3F6414

Q36936090-72449AFB-5F5B-445C-9B34-554A91AD01D7

Q36936090-78FD1E30-5C64-4582-8051-FF36857117D9

Q36936090-7D93ECC5-C33A-465F-BC4C-0AF951EB2F88

P304

Q36936090-9EF5910B-7100-483C-8964-6F864F9911CC

P31

Q36936090-F6609DF4-BC22-452E-BAD1-328F544C9D20

P356

Q36936090-16442636-16FE-45E0-B77E-903BDB541064

P433

Q36936090-58EF2B1B-4355-45BB-9339-08BB1147B33E

P478

Q36936090-0B82F0F4-0EAB-43BC-8927-F0080A15B51F

P50

Q36936090-3C21B9A4-A2FA-4FA5-AA01-1A0342654EE9

P577

Q36936090-3A3E47C4-6871-4715-98F8-2CEC8FC9DE9D

P698

Q36936090-29043986-C3AA-4B81-974C-0A0FC8F14A03

P932

Q36936090-24DD6279-1C23-476B-9DFB-83CBA067A5F9

P356

J.BBMT.2010.08.011

P1433

Biology of Blood and Marrow Transplantation

P1476

Availability of cord blood ext ...... racial and ethnic minorities.

@en

P2093

Andromachi Scaradavou

http://www.w3.org/2001/XMLSchema#string

Courtney E Byam

http://www.w3.org/2001/XMLSchema#string

Deborah S Wells

http://www.w3.org/2001/XMLSchema#string

Esperanza B Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Glenn Heller

http://www.w3.org/2001/XMLSchema#string

James W Young

http://www.w3.org/2001/XMLSchema#string

Juliet N Barker

http://www.w3.org/2001/XMLSchema#string

Kathleen A Doshi

http://www.w3.org/2001/XMLSchema#string

Marcel R M van den Brink

http://www.w3.org/2001/XMLSchema#string

Rebecca M Hawke

http://www.w3.org/2001/XMLSchema#string

P2860

Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.

A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions.

Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match.

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Hematopoietic stem-cell transplantation.

Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies

Cord blood transplantation: state of the art.

P304

1541-1548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2010.08.011

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20800103

http://www.w3.org/2001/XMLSchema#string

P932

3685152

http://www.w3.org/2001/XMLSchema#string